Much of the current debate centers on whether race should be a criterion for inclusion in clinical trials – and, by extension, whether drug labeling should mention race specifically. Although the issues are complicated, the solution is simple: follow the data.
目前争论的核心问题是种族是否应当被纳入临床试验的标准——以及推而广之，药品标签是否应该特别提到种族问题。这一复杂问题的解决办法其实非常简单：那就是让数据说话。